From antibiotic resistance to emerging viral threats, the global demand for new medicines is intensifying, yet traditional drug discovery pipelines remain slow and expensive. A new scientific review ...
And there's more than one way to monetize this technology.
In a landmark development for Indian life sciences and biotechnology, Hyderabad-based SCIINV Biosciences has developed India’s first AI-driven antimicrobial candidate using an advanced ...
Explore the impact of AI in drug discovery as 2026 promises critical clinical results and industry transformations.
Hosted on MSN
AI is helping doctors repurpose old drugs for new cures: 'The solution is in your neighborhood pharmacy'
When David Fajgenbaum was in medical school, he was diagnosed with an incurable illness called Castleman disease. He was 25 years old when doctors told him “there’s nothing we can do,” and a priest ...
Using AI, CDT Equity Inc. identifies a novel therapeutic indication for its lead programmes, supported by successful pre-clinical trial data NAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 26, 2025 ...
Hyderabad-based SCIINV Biosciences has identified a new AI-driven repurposed antibiotic now entering human clinical trials. The breakthrough, backed by Whale Tank Biocatalyst, reduces development time ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Two organizations with vast ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results